HealthEquity (NASDAQ:HQY – Get Rating) had its price target lifted by Deutsche Bank Aktiengesellschaft from $52.00 to $62.00 in a report issued on Thursday, The Fly reports. Deutsche Bank Aktiengesellschaft’s price objective would indicate a potential upside of 15.89% from the stock’s previous close.
A number of other equities analysts have also commented on HQY. TheStreet lowered shares of HealthEquity from a “c” rating to a “d+” rating in a research report on Tuesday, December 7th. Raymond James lowered shares of HealthEquity from a “strong-buy” rating to an “outperform” rating and lowered their price target for the company from $90.00 to $70.00 in a report on Tuesday, December 7th. Zacks Investment Research raised shares of HealthEquity from a “strong sell” rating to a “buy” rating and set a $58.00 price target on the stock in a report on Tuesday, February 8th. JPMorgan Chase & Co. lowered their price target on shares of HealthEquity from $82.00 to $56.00 and set an “overweight” rating on the stock in a report on Tuesday, December 21st. Finally, Barrington Research lowered their price target on shares of HealthEquity from $80.00 to $55.00 and set an “outperform” rating on the stock in a report on Tuesday, December 7th. Two equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. According to data from MarketBeat, HealthEquity presently has an average rating of “Buy” and a consensus target price of $71.82.
HealthEquity stock opened at $53.50 on Thursday. The firm’s 50-day moving average is $49.77 and its 200-day moving average is $58.29. The company has a debt-to-equity ratio of 0.49, a quick ratio of 7.14 and a current ratio of 7.14. HealthEquity has a 1 year low of $36.81 and a 1 year high of $85.98. The company has a market cap of $4.47 billion, a P/E ratio of -764.18, a PEG ratio of 3.67 and a beta of 1.05.
HealthEquity (NASDAQ:HQY – Get Rating) last released its earnings results on Monday, December 6th. The company reported $0.35 EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.35. The firm had revenue of $180.00 million for the quarter, compared to analysts’ expectations of $185.44 million. HealthEquity had a negative net margin of 0.82% and a positive return on equity of 4.60%. HealthEquity’s quarterly revenue was up .3% on a year-over-year basis. During the same quarter last year, the company earned $0.30 EPS. As a group, sell-side analysts predict that HealthEquity will post 0.82 earnings per share for the current year.
In other HealthEquity news, VP Angelique Christine Hill sold 6,297 shares of the company’s stock in a transaction that occurred on Friday, December 10th. The stock was sold at an average price of $41.10, for a total transaction of $258,806.70. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Adrian T. Dillon purchased 12,375 shares of HealthEquity stock in a transaction on Tuesday, December 14th. The shares were purchased at an average cost of $40.47 per share, with a total value of $500,816.25. The disclosure for this purchase can be found here. 2.80% of the stock is currently owned by corporate insiders.
A number of large investors have recently added to or reduced their stakes in the business. Carroll Investors Inc acquired a new stake in shares of HealthEquity in the 4th quarter valued at approximately $25,000. IndexIQ Advisors LLC acquired a new stake in shares of HealthEquity in the 4th quarter valued at approximately $27,000. Exchange Traded Concepts LLC acquired a new stake in shares of HealthEquity in the 3rd quarter valued at approximately $43,000. Pinebridge Investments L.P. acquired a new stake in shares of HealthEquity in the 4th quarter valued at approximately $31,000. Finally, Dark Forest Capital Management LP acquired a new stake in shares of HealthEquity in the 3rd quarter valued at approximately $95,000. 96.68% of the stock is owned by hedge funds and other institutional investors.
HealthEquity Company Profile (Get Rating)
HealthEquity, Inc provides range of solutions for managing health care accounts. The firm’s offers its solutions for employers, health plans, brokers, consultants and financial advisors. Its services include HAS, FSA, HRA, DCRA, 401(k), Commuter, COBRA and HIA. It also offers products like healthcare saving and spending platform, health savings accounts, investment advisory services, reimbursement arrangements, and healthcare incentives.